XML 41 R24.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT AND GEOGRAPHIC INFORMATION
 12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
SEGMENT AND GEOGRAPHIC INFORMATION SEGMENT AND GEOGRAPHIC INFORMATION
The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.
•The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the Instruments business, which sells more than 40,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.
•The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.
The Corporate and other category includes (i) various executive, finance, human resource, information systems and legal functions, (ii) brand management, and (iii) share-based compensation costs.
The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions, and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by reportable segment for the years ended December 31, 2020, 2019 and 2018 are as follows:
 Years Ended December 31,
 202020192018
 (In thousands)
Segment Net Sales
Codman Specialty Surgical$894,831 $996,206 $963,929 
Orthopedics and Tissue Technologies477,037 521,351 508,512 
Total revenues$1,371,868 $1,517,557 $1,472,441 
Segment Profit
Codman Specialty Surgical$356,657 $395,019 $363,336 
Orthopedics and Tissue Technologies159,630 144,638 149,510 
Segment profit516,287 539,657 512,846 
Amortization(27,757)(27,028)(21,160)
Corporate and other(337,160)(418,869)(380,688)
Operating income$151,370 $93,760 $110,998 
The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.
The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:
 United States*EuropeAsia PacificRest of the WorldConsolidated
 (In thousands)
Total revenue, net:
2020$971,975 $172,689 $157,174 $70,030 $1,371,868 
20191,077,379 197,468 157,391 85,319 1,517,557 
20181,045,887 201,354 144,253 80,947 1,472,441 
Total long-lived assets:
2020$324,893 $38,812 $13,121 $5,577 $382,403 
2019383,652 47,325 8,598 7,143 446,718 
* Includes long-lived assets in Puerto Rico.